Thomas LeBlanc

Thomas LeBlanc, MD

Duke Cancer Institute

Conference Co-Chair

Biography

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCO is Associate Professor of Medicine with Tenure in the Division of Hematologic Malignancies and Cellular Therapy (HMCT) at the Duke University School of Medicine, and founding Director of the Cancer Patient Experience Research Program (CPEP) in the Duke Cancer Institute (DCI). He serves as the Chief Patient Experience and Safety Officer for the DCI, and the Director of Outcomes Research for the Division of HMCT. Dr. LeBlanc is board-certified in medical oncology and in hospice and palliative medicine, and his practice focuses on the care of patients with blood cancers, particularly those with acute leukemias and myeloid malignancies. His program of research focuses on palliative care and patient experience issues in hematology.

Financial Disclosure

Pfizer

Professional Services

Gilead

Professional Services

Lilly

Professional Services

Novartis

Professional Services

Astellas

Professional Services

Taiho

Professional Services

GSK

Professional Services

Syndax

Professional Services

Jazz

Grant Or Contract

Rigel

Professional Services

BMS/Celgene

Professional Services

Novo Nordisk

Professional Services

Menarini-Stemline

Professional Services

Geron

Professional Services

DosenTrx

Stock Options

ThymeCare

Stock Options

AbbVie/Genentech

Professional Services

Agios/Servier

Professional Services

UpToDate Inc.

Professional Services